United States v. Purdue Pharma L.P. — Plea Agreement (October 2020)

Filed under: The Opioid Epidemic

Summary

Purdue Pharma's federal plea agreement admitting felony misbranding and fraud conspiracies in the marketing of OxyContin, as released by the Department of Justice.

Inline Preview

PDF preview requires a browser with native PDF rendering. Open in new tab if it does not render below.